Search results
What Could This Drug News Mean for AbbVie?
Motley Fool· 2 years agoIn late July, AbbVie (NYSE: ABBV) applied for a new indication with the European Medicines Agency (EMA) for Rinvoq to treat adult patients with...
AbbVie's Humira gets a U.S. rival, but costs could stay high
Reuters via Yahoo Finance· 1 year agoU.S. patients will finally get access to cheaper versions of AbbVie Inc’s blockbuster arthritis drug...
Cost of cancer drugs: Some patients don't fill cancer drug prescriptions because of high cost
NBC News via Yahoo News· 2 years agoNew York resident Lynn Scarfuto, 72, spent several years working as a nurse navigator, helping...
Patients see 1st savings from Biden's drug price push, as Pharma lines up its lawyers
ABC News via Yahoo News· 3 months agoLast year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey...
Hepatitis C Treatment Costs: What to Expect
Verywell Health via Yahoo News· 2 years agoHepatitis C is a liver infection caused by the hepatitis C virus (HCV). Prior to the introduction of a new class of drugs called direct-acting antivirals...
